HepG2（人肝癌細(xì)胞）
CBP60199
詢(xún) 價(jià)
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| I. General information | |
| Cell Name: | HepG2 |
| Background: | Established from the tumor tissue of a 15-year-old Argentine boy with well differentiated hepatocellular carcinoma in 1975; cell line is patented; cells were described to not harbor a hepatitis B virus genome; cells reportedly produce a variety of proteins: alpha-fetoprotein, albumin, alpha2-macroglobulin, alpha1-antitrypsin, transferrin, alpha1-antichymotrypsin, haptoglobin, ceruloplasmin, plasminogen, complement (C3, C4), C3 activator, fibrinogen, alpha1-acid glycoprotein, alpha2-HS glycoprotein, ß-lipoprotein, retinol binding protein. They have been grown successfully in large scale cultivation systems. The cells will respond to stimulation with human growth hormone. |
| Species: | Homo sapiens, human |
| Tissue: | Liver |
| Disease: | Hepatocellular carcinoma |
| Gender: | Male, 15 years, Caucasian |
| Morphology: | Epithelial-like cells growing as monolayers and in small aggregates |
| Growth Mode: | Adherent |
| Doubling Time: | 50~60hrs |
| DNA Profile: |
Amelogenin: X,Y |
| Culture Medium: |
MEM + 10% FBS+ 1% Non Essential Amino Acids (NEAA) + 1mM Sodium Pyruvate (NaP) HepG2完全培養(yǎng)基，# CBP60199M |
| Cryopreservation medium: | 90% Complete Medium+10%DMSO |
| Comments: | For more information, please contact Cobioer (4008-750-250). |
